AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration
The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287 · cited 2×
“(iv) In contrast to JNK pathways, the upregulation of ERKs cannot be linked to neuronal degeneration, but rather to physiological programs and neuroprotection (Xia et al., 1995).”
BackgroundIschemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · cited 1×
“…and energy delivery; after some time, energy depletion, breakdown of membrane functions and rise of intracellular calcium occurs in parallel with transparency of the blood-brain-barrier, activation of microglia and release of cytokines from multiple cellular sources (reviewed by Lipton, 1999).”
BackgroundHerdegen, T., & Leah, J. D. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00018-6 · Cited by 1,350 · cited 5×
“This temporally staggered, but nevertheless congruent, AP-1 expression pattern is visible at mRNA and protein level following transynaptic stimulation e.g. following kainic acid or noxious stimulation (Beer et al., 1998; Herdegen and Leah, 1998).”
BackgroundInfluentialSelf-citationSelective interaction of JNK protein kinase isoforms with transcription factors.
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,338 · cited 9×
“Recently, we have de®ned the distal jun2 (and to a lesser extent the proximal jun1) response element as regulatory elements for ATF-2 and c-Jun mediated c-jun induction in the brain.”
BackgroundInfluentialAbsence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,238 · cited 7×
“The elevated resistance to kainic acid indicates that JNK knockout (Yang et al., 1997) and c-JunAA knock in (Behrens et al., 1999) have profound in¯uence on the development of de®ned pre-existing structures which realize neuronal excitation.”
BackgroundInfluentialRaivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844 · cited 2×
“(i) Neurons can be killed by apoptotic programs which include AP-1 activity (Behrens et al., 1999), but in parallel, apoptosis is also involved in the termination of microglial activity resembling the processes in immune cells (Raivich et al., 1999).”
Backgroundβ-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F.-T., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 819 · cited 10×
“In contrast to ASK1, the Akt kinase (also called protein kinase B) which acts downstream of phosphatidylinositol-3-kinase (PI3-K), distinctly inhibits the activation of JNK and c- Oncogene Jun and protects against neuronal apoptosis (Levresse et al., 2000).”
BackgroundInfluentialA c-jun dominant negative mutant protects sympathetic neurons against programmed cell death
Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., & Rubin, L. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90331-3 · Cited by 796 · cited 1×
“Transfection of sympathetic neurons with wildtype c-Jun (Ham et al., 1995) or with MEKK1 (and subsequent activation of JNK and c-Jun) (Eilers et al., 1998) induced apoptosis even in the presence of NGF, whereas cell death was prevented by transfection with dominant negative JNK1 (Eilers et al.,…”
BackgroundActivation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
Han, J., Jiang, Y., Li, Z., Kravchenko, V. V., & Ulevitch, R. J. (1997) · Nature · doi:10.1038/386296a0 · Cited by 766 · cited 1×
“Besides ATF-2 and c-Jun, the p38 pathway with the transcription factor MEF2C has emerged as a novel regulator of the c-jun induction (Han et al., 1997; Marinissen et al., 1999); interestingly, MEF2C can mediate neuronal survival and neurite elongation during development (Mao et al., 1999).”
BackgroundBehrens, A., Sibilia, M., & Wagner, E. F. (1999) · Nature Genetics · doi:10.1038/6854 · Cited by 676 · cited 9×
“Finally, primary hippocampal/cortical neurons from c-JunAA mutants are protected against kainic acid-induced apoptosis inspite of unaltered JNK activity (Behrens et al., 1999).”
BackgroundInfluential
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
“For instance, the c-Jun NH2-terminal kinases (JNKs) subfamily of the MAPK are considered as essential signaling molecules in neurodegenerative processes of the mammalian brain (297).”
BackgroundPathobiology of neuropathic pain
Zimmermann, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01303-6 · Cited by 937
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Biological properties of garlic and garlic‐derived organosulfur compounds
Iciek, M., Kwiecień, I., & Włodek, L. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20474 · Cited by 458
Microglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Rosenberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7079-x · Cited by 300
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia
Waetzig, V., Czeloth, K., Hidding, U., Mielke, K., Kanzow, M., Brecht, S., Goetz, M., Lucius, R., Herdegen, T., & Hanisch, U.-K. (2005) · Glia · doi:10.1002/glia.20173 · Cited by 290
Self-citationKataoka, A., Tozaki‐Saitoh, H., Koga, Y., Tsuda, M., & Inoue, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05744.x · Cited by 121
“…and chemokines from microglia, several transcription factors, such as nuclear factor jB (O’Neill and Kaltschmidt 1997), Activating Protein 1 (AP-1) (Herdegen and Waetzig 2001), Signal Transducers and Activator of Transcription (STAT) (Campbell 2005), peroxisome proliferator-activated receptor c…”
BackgroundAltered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients
Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., & Moutsatsou, P. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.006 · Cited by 58
Metadata
- Authors
- Herdegen, T., & Waetzig, V.
- Venue
- Oncogene
- Published
- 2001-04-30
- Volume
- 20
- Issue
- 19
- Pages
- 2424-2437
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2326067170
- Cited by
- 191
- References
- 124
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.